JAGX: Jaguar Health Inc
今日JAGX汇率已更改5.33%。当日,交易品种以低点1.66和高点1.82进行交易。
关注Jaguar Health Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
JAGX新闻
- Jaguar Health reports positive results in MVID treatment trial
- Jaguar Health在Lytham Partners大会上:关于Crofelemer的战略见解
- Jaguar Health at Lytham Partners: Strategic Insights on Crofelemer
- Jaguar Health provides drug for expanded access to treat rare disease
- Jaguar Health在新兴增长会议上:战略增长路径
- Jaguar Health at Emerging Growth Conference: Strategic Path to Growth
- Jaguar Health receives $250,000 FDA grant for canine diarrhea drug study
- Jaguar Health at Emerging Growth Conference 85: Strategic Drug Development Insights
- Jaguar Health to meet with FDA on crofelemer for rare pediatric disease
- Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end
- Clean Inc. and Sono Group NV at Emerging Growth Conference: Strategic Innovations
- Proof-of-Concept Results Show Jaguar Health’s Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
- Jaguar Health considers cryptocurrency for treasury reserves
- Jaguar Health Board authorizes crypto treasury reserve
- Jaguar Health seeks EU approval for dog diarrhea treatment
- Jaguar Health extends maturity date for $2.57 million in notes
- Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
- First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
- REMINDER: Jaguar Health to Conduct Fireside Chat 9AM ET June 10 as Part of Lytham Partners’ Spring 2025 Spotlight Series
- Jaguar Health Eyes FDA Orphan Drug Designation for Crofelemer
- Jaguar Health to Conduct Fireside Chat June 10 Regarding Company’s Efforts to Further its Orphan Disease Development Programs as Part of Lytham Partners’ Spring 2025 Spotlight Series
- Jaguar Health announces $1.5 million direct offering
- First Patient Randomized in Jaguar Health’s Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID)
- Jaguar Health Reports First Quarter 2025 Financials
常见问题解答
JAGX股票今天的价格是多少?
Jaguar Health Inc股票今天的定价为1.78。它在1.66 - 1.82范围内交易,昨天的收盘价为1.69,交易量达到84。JAGX的实时价格图表显示了这些更新。
Jaguar Health Inc股票是否支付股息?
Jaguar Health Inc目前的价值为1.78。股息政策取决于公司,而投资者也会关注72.82%和USD。实时查看图表以跟踪JAGX走势。
如何购买JAGX股票?
您可以以1.78的当前价格购买Jaguar Health Inc股票。订单通常设置在1.78或2.08附近,而84和7.23%显示市场活动。立即关注JAGX的实时图表更新。
如何投资JAGX股票?
投资Jaguar Health Inc需要考虑年度范围0.20 - 15.48和当前价格1.78。许多人在以1.78或2.08下订单之前,会比较-11.00%和。实时查看JAGX价格图表,了解每日变化。
Jaguar Health, Inc.股票的最高价格是多少?
在过去一年中,Jaguar Health, Inc.的最高价格是15.48。在0.20 - 15.48内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Jaguar Health Inc的绩效。
Jaguar Health, Inc.股票的最低价格是多少?
Jaguar Health, Inc.(JAGX)的最低价格为0.20。将其与当前的1.78和0.20 - 15.48进行比较,可以发现潜在的长期切入点。观看JAGX在图表上的实时走势以获取更多详细信息。
JAGX股票是什么时候拆分的?
Jaguar Health Inc历史上曾经历过股票拆分。这些变化在公司行动后的、1.69和72.82%中可见。
- 前一天收盘价
- 1.69
- 开盘价
- 1.66
- 卖价
- 1.78
- 买价
- 2.08
- 最低价
- 1.66
- 最高价
- 1.82
- 交易量
- 84
- 日变化
- 5.33%
- 月变化
- -11.00%
- 6个月变化
- -58.89%
- 年变化
- 72.82%
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 417
- 预测值
- 前值
- 414
- 实际值
- 549
- 预测值
- 前值
- 548
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值
- 实际值
- 预测值
- 前值